Scarica l'app Stockscreener
7.3091
0.41%
-0.0209
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.33
Aprire:
$7.34
Volume 24 ore:
517.57K
Relative Volume:
0.34
Capitalizzazione di mercato:
$844.81M
Reddito:
-
Utile/perdita netta:
$-242.30M
Rapporto P/E:
-2.9472
EPS:
-2.48
Flusso di cassa netto:
$-192.10M
1 W Prestazione:
+0.97%
1M Prestazione:
+49.59%
6M Prestazione:
-5.68%
1 anno Prestazione:
-13.51%
Intervallo 1D:
$7.14
$7.475
Intervallo di 1 settimana:
$6.92
$7.50
Portata 52W:
$3.72
$12.61
Cogent Biosciences Inc Stock (COGT) Company Profile
Nome
Cogent Biosciences Inc
Settore
Industria
Telefono
617-945-5576
Indirizzo
275 WYMAN STREET, WALTHAM
Confronta COGT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
7.31 | 844.81M | 0 | -242.30M | -192.10M | -2.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.43 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
523.86 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.50 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
561.27 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.30 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-12-11 | Downgrade | Needham | Buy → Hold |
| 2024-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | Iniziato | Citigroup | Buy |
| 2023-12-11 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-12-08 | Iniziato | JP Morgan | Overweight |
| 2023-04-28 | Iniziato | Robert W. Baird | Outperform |
| 2023-03-27 | Ripresa | H.C. Wainwright | Buy |
| 2022-12-14 | Iniziato | Needham | Buy |
| 2022-06-28 | Iniziato | Guggenheim | Buy |
| 2021-10-11 | Iniziato | H.C. Wainwright | Buy |
| 2021-06-09 | Ripresa | Jefferies | Buy |
| 2020-12-23 | Iniziato | Piper Sandler | Overweight |
| 2020-10-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Cogent Biosciences Inc Borsa (COGT) Ultime notizie
(COGT) Investment Analysis - news.stocktradersdaily.com
Cogent Biosciences (NASDAQ:COGT) Given “Hold” Rating at Needham & Company LLC - Defense World
Cogent Biosciences (COGT) Receives Reiterated 'Hold' Rating by N - GuruFocus
Cogent Biosciences (COGT) Receives Reiterated 'Hold' Rating by Needham | COGT Stock News - GuruFocus
Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) Target Price at $14.57 - Defense World
Bank of America Corp DE Reduces Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Term Loan Facility - Leerink Partners
Cogent Biosciences, Inc. (NASDAQ:COGT) Stock Position Lowered by California State Teachers Retirement System - Defense World
Latham & Watkins Leads on US$400 Million Debt Financing Facility for Cogent Biosciences - Latham & Watkins LLP
Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing - GlobeNewswire
Cogent Biosciences Secures $400 Million in Financing - citybiz
Cogent Biosciences, Inc. announced that it expects to receive $400 million in funding - MarketScreener
Cogent Biosciences Gets $400 Million Debt Financing - MarketScreener
Cogent Biosciences (COGT) Secures $400M Financing for Growth Ini - GuruFocus
Cogent Secures Up To $400 Mln Debt Facility From SLR Capital For Growth Strategy - Nasdaq
Cogent Biosciences Secures $400 Million Debt Financing Facility to Support Growth and Upcoming Bezuclastinib Launch - Nasdaq
Cogent Biosciences Lands Massive $400M Financing Deal as 3 Pivotal Trial Results Loom in 2025 - Stock Titan
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 17,741 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Two Sigma Investments LP Sells 4,633 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Two Sigma Advisers LP Has $148,000 Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Ameriprise Financial Inc. Acquires 9,459 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
(COGT) On The My Stocks Page - news.stocktradersdaily.com
Nuveen Asset Management LLC Has $2.44 Million Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
ProShare Advisors LLC Increases Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences (NASDAQ:COGT) Trading Down 5.7% – Time to Sell? - Defense World
Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $25.00 at JPMorgan Chase & Co. - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences (NASDAQ:COGT) Shares Up 11.6% Following Analyst Upgrade - Defense World
COGT: JP Morgan Raises Price Target for Cogent Biosciences | COG - GuruFocus
Cogent Biosciences Announces Participation in the Jefferies Glob - GuruFocus
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference - GlobeNewswire
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference | COGT Stock News - GuruFocus
JPMorgan Ups Price Target for Cogent Biosciences (COGT) to $25 | - GuruFocus
Cogent Biosciences Reveals Latest Precision Therapy Progress Plus New Employee Stock Options - Stock Titan
Deutsche Bank AG Reduces Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Jane Street Group LLC Decreases Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
This Cogent Biosciences Insider Increased Their Holding By 2,085% Last Year - simplywall.st
When (COGT) Moves Investors should Listen - news.stocktradersdaily.com
BNP Paribas Financial Markets Buys Shares of 66,784 Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Janus Henderson Group PLC Has $227,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Q2 EPS Estimate for Cogent Biosciences Raised by Analyst - Defense World
HC Wainwright Has Lowered Expectations for Cogent Biosciences (NASDAQ:COGT) Stock Price - Defense World
Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) PT at $14.29 - Defense World
Cogent Biosciences (COGT) Maintains 'Buy' Rating with Adjusted P - GuruFocus
Cogent Biosciences (COGT) Maintains 'Buy' Rating with Adjusted Price Target | COGT Stock News - GuruFocus
Cogent Biosciences (COGT) Price Target Reduced by H.C. Wainwrigh - GuruFocus
Northern Trust Corp Grows Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Where are the Opportunities in (COGT) - news.stocktradersdaily.com
Price T Rowe Associates Inc. MD Has $388,000 Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Wall Street Analysts Believe Cogent Biosciences (COGT) Could Rally 224.37%: Here's is How to Trade - MSN
Cogent Biosciences Inc Azioni (COGT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.37%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):